Even when access and adherence to treatment are similar, rates of locoregional recurrence are nearly two times higher among Black and Asian women compared with White women, new data show.
A new study found that surgery improved overall survival for patients with tumors 1.1 to 2.0 cm but not 1 cm or smaller. The results may provide some clarity as to who can benefit from resection.
In a debate held recently on the use of neoadjuvant therapy for high-risk intrahepatic cholangiocarcinoma, both sides agreed that more research is needed.
Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.
Most women undergo primary breast cancer surgery within 8 weeks of diagnosis. Later may be associated with worse survival but some argue earlier surgery is not always better.